DZ3039A1 - Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae. - Google Patents

Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae.

Info

Publication number
DZ3039A1
DZ3039A1 DZ000081A DZ000081A DZ3039A1 DZ 3039 A1 DZ3039 A1 DZ 3039A1 DZ 000081 A DZ000081 A DZ 000081A DZ 000081 A DZ000081 A DZ 000081A DZ 3039 A1 DZ3039 A1 DZ 3039A1
Authority
DZ
Algeria
Prior art keywords
treatment
streptococcus pneumoniae
pneumoniae infections
monthly doses
monthly
Prior art date
Application number
DZ000081A
Other languages
English (en)
French (fr)
Inventor
Thomas Reeves Parr
Magaret Mary Wasilewski
Michael Lee Zeckel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DZ3039A1 publication Critical patent/DZ3039A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DZ000081A 1999-05-03 2000-05-02 Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae. DZ3039A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03

Publications (1)

Publication Number Publication Date
DZ3039A1 true DZ3039A1 (fr) 2004-03-27

Family

ID=22453188

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000081A DZ3039A1 (fr) 1999-05-03 2000-05-02 Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae.

Country Status (29)

Country Link
EP (1) EP1175222B1 (hu)
JP (1) JP2002543146A (hu)
KR (1) KR100757165B1 (hu)
CN (1) CN1349407A (hu)
AR (1) AR023827A1 (hu)
AT (1) ATE284702T1 (hu)
AU (1) AU774647B2 (hu)
BR (1) BR0010244A (hu)
CA (1) CA2372790A1 (hu)
CZ (1) CZ296127B6 (hu)
DE (1) DE60016734T2 (hu)
DZ (1) DZ3039A1 (hu)
EA (1) EA004295B1 (hu)
HK (1) HK1044707B (hu)
HR (1) HRP20010808A2 (hu)
HU (1) HUP0200940A3 (hu)
IL (2) IL145582A0 (hu)
MY (1) MY123542A (hu)
NO (1) NO20015291L (hu)
NZ (1) NZ514467A (hu)
PE (1) PE20010292A1 (hu)
PL (1) PL353444A1 (hu)
SK (1) SK285970B6 (hu)
SV (1) SV2002000065A (hu)
TR (1) TR200103211T2 (hu)
TW (1) TWI255716B (hu)
UA (1) UA73937C2 (hu)
WO (1) WO2000066144A2 (hu)
ZA (1) ZA200108013B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3006038B1 (en) * 2008-08-30 2024-07-03 The Medicines Company Single doses of oritavancin for treating or preventing a bacterial infection
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
US20160206688A1 (en) * 2013-08-26 2016-07-21 The Medicines Company Methods for treating bacteremia and osteomyelitis using oritavancin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
IL145582A0 (en) 2002-06-30
TWI255716B (en) 2006-06-01
AU4329200A (en) 2000-11-17
WO2000066144A2 (en) 2000-11-09
TR200103211T2 (tr) 2002-02-21
UA73937C2 (en) 2005-10-17
HUP0200940A3 (en) 2002-10-28
MY123542A (en) 2006-05-31
NO20015291L (no) 2001-12-17
HRP20010808A2 (en) 2002-12-31
SK285970B6 (sk) 2007-12-06
EP1175222A2 (en) 2002-01-30
EA200101171A1 (ru) 2002-04-25
CN1349407A (zh) 2002-05-15
DE60016734D1 (de) 2005-01-20
HUP0200940A2 (en) 2002-08-28
JP2002543146A (ja) 2002-12-17
EP1175222B1 (en) 2004-12-15
ATE284702T1 (de) 2005-01-15
AU774647B2 (en) 2004-07-01
KR100757165B1 (ko) 2007-09-07
SK15572001A3 (sk) 2003-05-02
WO2000066144A3 (en) 2001-04-12
DE60016734T2 (de) 2005-12-08
NZ514467A (en) 2005-01-28
SV2002000065A (es) 2002-12-02
AR023827A1 (es) 2002-09-04
ZA200108013B (en) 2003-03-26
CZ296127B6 (cs) 2006-01-11
NO20015291D0 (no) 2001-10-29
BR0010244A (pt) 2002-01-08
HK1044707A1 (en) 2002-11-01
CZ20013949A3 (cs) 2002-07-17
HK1044707B (zh) 2005-09-30
PE20010292A1 (es) 2001-03-07
CA2372790A1 (en) 2000-11-09
EA004295B1 (ru) 2004-02-26
KR20020008173A (ko) 2002-01-29
IL145582A (en) 2008-12-29
PL353444A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
DZ1877A1 (fr) Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
DZ1876A1 (fr) Médicaments pour administration orale.
MA26822A1 (fr) Composes pour le traitement d'une ischemie.
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
DE69516524D1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
NL1001950C2 (nl) Verpakken van pleisters.
BR9706897B1 (pt) forma de dosagem farmacêutica.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
MA25411A1 (fr) Microorganismes attenues pour le traitement d'infection.
FR2684554B1 (fr) Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
EE9700014A (et) Uus peroraalne ravimvorm, mis sisaldab omeprasooli magneesiumsoola
FR2698268B1 (fr) Composition photoprotectrice administrée par voie orale.
DZ3039A1 (fr) Doses mensuelles pour le traitement d'infections par streptococcus pneumoniae.
FR2684546B3 (fr) Instrument de traitement, en particulier pour le traitement cosmetique du visage.
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
FR2703383B1 (fr) Crépissage fin pour l'intérieur.
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
DZ1903A1 (fr) Oligonucléotides pour inhiber le role ders isoprényl protéine transférases.
FI951655A (fi) H.pylori -infektioiden hoito
ATE308551T1 (de) Oligosaccharide die sich vom ribose-ribtol- phosphat herleiten und impfstoffe, die diese oligosaccharide enthalten
IT1289238B1 (it) Composizioni farmaceutiche per il trattamento di infezioni virali comprendenti una 4 arilcumarina
AU4145999A (en) Topical drug for the treatment of viral infections
ITRM920305A0 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.